Vitreoretinal Interface

Retina: Fourth Edition

Volumn 3-3, Issue , 2005, Pages 1921-1989

  Green, W Richard ^a   Sebag, J ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84917070368     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-323-02598-0.50120-8     Document Type: Chapter

References (507)

1. Fine BS, Tousimus AJ The structure of the vitreous body and the suspensory ligaments of the lens. Arch Ophthalmol 1961, 65:95-110.
2. Hogan MJ, Alvarado JA, Weddell JE Histology of the human eye: an atlas and textbook 1971, WB Saunders, Philadelphia.
3. Teng CC, Chi HH Vitreous changes and the mechanism of retinal detachment. Am J Ophthalmol 1957, 44:335-356.
4. Schepens CL. Personal communication, 1986.
5. Grignolo A Fibrous components of the vitreous body. Arch Ophthalmol 1952, 47:760-774.
6. Worst JG Cisternal systems of the fully developed vitreous body in the young adult. Trans Ophthalmol Soc UK 1977, 97:550-554.
7. Sebag J, Balazs EA Human vitreous fibres and vitreoretinal disease. Trans Ophthalmol Soc UK 1984, 104:123-128.
8. Gartner J Electron-microscopic study on the fibrillar network and fibrocyte-collagen interactions in the vitreous cortex at the ora serrata of human eyes with special regard to the role of disintegrating cells. Exp Eye Res 1986, 42:21-23.
9. Sebag J The vitreous: structure, function, and pathobiology 1989, Springer-Verlag, New York.
10. Sebag J Surgical anatomy of vitreous and the vitreo-retinal interface. Duane's clinical ophthalmology, vol 6 1992, JB Lippincott, Philadelphia. W. Tasman, E.A. Jaeger (Eds.).
11. Sebag J Age-related changes in human vitreous structure. Graefes Arch Clin Exp Ophthalmol 1987, 225:89-93.
12. Sebag J Is pharmacologic vitreolysis brewing?. Retina 2002, 22:1-3.
13. Sebag J Vitreous effects of cataract surgery and YAG laser capsulotomy: role in postoperative retinal detachment. Anterior and posterior segment surgery: mutual problems and common interests. ACTA of the Fifth International Congress on Vitreoretinal Surgery, Rome, Sept 24-27 1998, Ophthalmic Communications Society, New York. M. Stirpe (Ed.).
14. Snowden JM, Swann DA Vitreous structure. V. The morphology and thermal stability of vitreous collagen fibers and comparison to articular cartilage (type II) collagen. Invest Ophthalmol Vis Sci 1980, 19:610-618.
15. Fine BS, Yanoff M Ocular histology: a text and atlas 1979, Harper & Row, New York. 2nd edn.
16. Szirmai JA, Balazs EA Studies on the structure of the vitreous body. III. Cells in the cortical layer. Arch Ophthalmol 1958, 59:34-48.
17. Balazs EA Structure of the vitreous gel. Acta XVII. Core Ophthalmol 1954, 2:1019-1024.
18. Stern WH, Lewis GP, Erickson PA, et al. Fluorouracil therapy for proliferative vitreoretinopathy after vitrectomy. Am J Ophthalmol 1983, 96:33-42.
19. Grabner G, Boltz G, Forster O Macrophage-like properties of human hyalocytes. Invest Ophthalmol Vis Sci 1980, 19:333-340.
20. Wolter JR The macrophage of the human vitreous body. Am J Ophthalmol 1960, 49:99-107.
21. Hultsch E Vitreous structure and ocular inflammation. Immunology and immunopathology of the eye 1979, Masson, New York. A.M. Silverstein, G.R. O'Connor (Eds.).
22. Gartner J The fine structure of the vitreous base of the human eye and pathogenesis of pars planitis. Am J Ophthalmol 1971, 71:1317-1327.
23. Balazs EA Physiology of the vitreous body. Proceedings of the Second Conference of the Retina Foundation 1960, Mosby, St Louis. C.L. Schepens (Ed.).
24. Hilding AC Normal vitreous, its attachments and dynamics during ocular movement. Arch Ophthalmol 1954, 52:497-514.
25. Hilding AC Alterations in the form, movement, and structure of the vitreous body in aphakic eyes. Arch Ophthalmol 1954, 52:699-709.
26. Balazs EA Molecular morphology of the vitreous body. The structure of the eye 1961, Academic Press, New York. G.K. Smelser (Ed.).
27. Ueno N, Sebag J, Hirokawa H, et al. Effects of visible-light irradiation on vitreous structure in the presence of a photosensitizer. Exp Eye Res 1987, 44:863-870.
28. Sebag J Ageing of the vitreous. Eye 1987, 1:254-262.
29. Fine BS Limiting membranes of the sensory retina and pigment epithelium: an electron microscopic study. Arch Ophthalmol 1961, 66:847-860.
30. Wolfe E The anatomy of the eye and orbit 1955, McGraw-Hill, New York.
31. Heegaard S, Jensen OA, Prause JU Structure and composition of the inner limiting membranes of the retina. SEM on frozen resin-cracked and enzyme-digested retinas of Macaca mulatta. Graefes Arch Clin Exp Ophthalmol 1986, 224:355-360.
32. Sebag J Vitreous biochemistry, morphology, and clinical examination. Duane's clinical ophthalmology, vol 5 1992, JB Lippincott, Philadelphia. W. Tasman, E.A. Jaeger (Eds.).
33. Sebag J Pharmacologic vitreolysis. (Editorial). Retina 1998, 18:1-3.
34. Kohno T, Sorgente N, Ishibashi T, et al. Immunofluorescent studies of fibronectin and laminin in the human eye. Invest Ophthalmol Vis Sci 1987, 28:506-514.
35. Foos RY Posterior peripheral retinal tears. Ann Ophthalmol 1974, 6:679-687.
36. Nagy AR, Goodnight R, Ryan SJ Conventional freeze-fracture and immunoelectron microscopy of the vitreoretinal junction. Invest Ophthalmol Vis Sci 1986, 28(suppl):24. (abstract).
37. Jerdan JA, Kao L, Glaser BM The inner limiting membrane: a modified basement membrane?. Invest Ophthalmol Vis Sci 1986, 27(suppl):230. (abstract).
38. Verstraeten T, Chapman C, Hartzer M, et al. Pharmacologic induction of PVD in the rabbit. Arch Ophthalmol 1993, 111:849.
39. Hageman GS, Russell SR Chondroitinase-mediated disinsertion of the primate vitreous body. Invest Ophthalmol Vis Sci 1994, 35:1260.
40. Sebag J ICG-assisted macular hole surgery: too pioneering? (Editorial). Am J Ophthalmol 2004, 137:744-746.
41. Nagata M, Robison WG Aldose reductase, diabetes, and thickening of the retinal inner limiting membrane. Invest Ophthalmol Vis Sci 1987, 28:1867-1869.
42. Robison WG, Kador PF, Akagi Y, et al. Prevention of basement membrane thickening in retinal capillaries by a novel inhibitor of aldose reductase, Tolrestant. Diabetes 1986, 35:295-299.
43. Robison WG, Kinoshita JH, Kador PF The polyol pathway in retinal microangiopathy. Drugs 1986, 32(suppl):19-22.
44. Sebag J, Buckingham B, Charles MA, et al. Biochemical abnormalities in vitreous of humans with proliferative diabetic retinopathy. Arch Ophthalmol 1992, 110:1472-1479.
45. Anderson DR Ultrastructure of the optic nerve head. Arch Ophthalmol 1970, 83:63-73.
46. Heegaard S, Jensen OA, Prause JU Structure of the vitreal face of the monkey optic disc (Macaca mulatta). SEM on frozen resin-cracked optic nerve heads supplemented by TEM and immunochemistry. Graefes Arch Clin Exp Ophthalmol 1988, 226:377-383.
47. Sebag J Anatomy and pathology of the vitreo-retinal interface. Eye 1992, 6:541-552.
48. Sebag J Vitreous pathobiology. Duane's clinical ophthalmology, vol 5 1992, JB Lippincott, Philadelphia. W. Tasman, E.A. Jaeger (Eds.).
49. Yamada E Some structural features of the foveal centralis in the human retina. Arch Ophthalmol 1969, 82:151-159.
50. Foos RY Vitreoretinal juncture: topographical variations. Invest Ophthalmol 1972, 11:801-808.
51. Roth AM, Foos RY Surface structure of the optic nerve head. I. Epipapillary membranes. Am J Ophthalmol 1972, 74:977-985.
52. Kishi S, Numaga T, Yoneya S, et al. Epivascular glia and paravascular holes in normal human retina. Graefes Arch Clin Exp Ophthalmol 1986, 224:124-130.
53. Polk TD, Gass DM, Green WR, et al. Familial internal limiting membrane dystrophy: a new sheen retinal dystrophy. Arch Ophthalmol 1997, 115:878-885.
54. Constable IJ, Horne R, Slatter DH, et al. Regeneration of retinal limiting membranes after chorioretinal biopsy in dogs. Invest Ophthalmol Vis Sci 1981, 20:246-251.
55. Mittleman D, Green WR, Michels RG, et al. Clinicopathologic correlation of an eye after surgical removal of an epiretinal membrane. Retina 1989, 9:143-147.
56. Foos RY, Gloor BP Vitreoretinal junction: healing of experimental wounds. Graefes Arch Clin Exp Ophthalmol 1975, 196:213-230.
57. Miller JW, Adamis AP, Shima DT, et al. Vascular endothelial growth factor/vascular permeability factor is temporally and spatially corrected with ocular angiogenesis in a primate model. Am J Pathol 1994, 145:574-584.
58. Miller B, Miller H, Patterson R, et al. Effect of the vitreous on retinal wound-healing. Graefes Arch Clin Exp Ophthalmol 1986, 224:576-579.
59. Sebag J Age-related differences in the human vitreo-retinal interface. Arch Ophthalmol 1991, 109:966-971.
60. Foos RY, Roth AM Surface structure of the optic nerve head. II. Vitreopapillary attachments and posterior vitreous detachment. Am J Ophthalmol 1973, 76:662-671.
61. Foos RY Vitreoretinal juncture over retinal vessels. Graefes Arch Clin Exp Ophthalmol 1977, 204:223-234.
62. Green WR Retina. Ophthalmic pathology: an atlas and text 1996, WB Saunders, Philadelphia. 4th edn. W.H. Spencer (Ed.).
63. Wolter JR Pores in the internal limiting membrane of the human retina. Acta Ophthalmol 1964, 42:971-974.
64. Kuwabara T, Cogan DG Studies of retinal vascular patterns. I. Normal architecture. Arch Ophthalmol 1960, 64:904-911.
65. Mutlu F, Leopold IH Structure of the human retinal vascular system. Arch Ophthalmol 1964, 71:93.
66. Hogan MJ The vitreous, its structure and relation to the ciliary body and retina. Invest Ophthalmol 1963, 2:418-445.
67. Foos RY, Allen RA Retinal tears and lesser lesions of the peripheral retina. Am J Ophthalmol 1967, 64:643-655.
68. Foos RY, Simons KB Vitreous in lattice degeneration of retina. Ophthalmology 1984, 91:452-457.
69. Spencer LM, Foos RY, Straatsma BR Meridional complexes and associated abnormalities of the peripheral retina. Am J Ophthalmol 1970, 70:697-713.
70. Byer NE Cystic retinal tufts and their relationship to retinal detachment. Arch Ophthalmol 1981, 99:1788-1790.
71. Foos RY Zonular traction tufts of the peripheral retina in cadaver eyes. Arch Ophthalmol 1969, 82:620-632.
72. Spencer LM, Straatsma BR, Foos RY Tractional degenerations of the peripheral retina. Transactions of the New Orleans Academy of Ophthalmology: Symposium on Retina and Retinal Surgery 1969, Mosby, St Louis.
73. Spencer LM, Foos RY, Straatsma BR Enclosed bays of the ora serrata: relationship to retinal tears. Arch Ophthalmol 1970, 83:421-425.
74. Rutnin U, Schepens CL Fundus appearance in normal eyes. II. The standard peripheral fundus and developmental variations. Am J Ophthalmol 1967, 64:840-852.
75. Foos RY, Spencer LM, Straatsma BR Trophic degenerations of the peripheral retina. Transactions of the New Orleans Academy of Ophthalmology: Symposium on retina and retinal surgery 1969, Mosby, St Louis.
76. Streeten BW, Bert M The retinal surface in lattice degeneration of the retina. Am J Ophthalmol 1972, 74:1201-1209.
77. Teng CC, Katzin KM An anatomic study of the periphery of the retina. I. Nonpigmented epithelial cell proliferation and hole formation. Am J Ophthalmol 1951, 34:1237-1248.
78. Okun E Gross and microscopic pathology in autopsy eyes. III. Retinal breaks without detachment. Am J Ophthalmol 1961, 51:369-391.
79. Rutnin U, Schepens CL Fundus appearance in normal eyes. III. Peripheral degenerations. Am J Ophthalmol 1967, 64:1040-1062.
80. Cibis PA Vitreoretinal pathology and surgery in retinal detachment 1965, Mosby, St Louis.
81. Foos RY Vitreous base, retinal tufts, and retinal tears: pathogenic relationships. Retina congress 1974, Appleton-Century-Crofts, New York. R.C. Pruett, C.D. Regan (Eds.).
82. Inomata H Electron microscopic observations of cystoid degeneration in the peripheral retina. Jpn J Ophthalmol 1966, 10:26-40.
83. Bradford JD, Wilkinson CP, Fransen SR Pseudophakic retinal detachment: the relationships between retinal tears and the time following cataract surgery at which they occur. Retina 1989, 9:181-186.
84. Byer NE Lattice degeneration of the retina. Surv Ophthalmol 1979, 23:213-247.
85. Straatsma BR, Allen RA Lattice degeneration of the retina. Trans Am Acad Ophthalmol Otolaryngol 1962, 66:600-613.
86. Straatsma BR, Foos RY, Feman SS Degenerative diseases of the peripheral retina. Clinical ophthalmology, vol 3 1986, Harper & Row, Philadelphia. T.D. Duane (Ed.).
87. Straatsma BR, Zeegen PD, Foos RY, et al. Lattice degeneration of the retina. Trans Am Acad Ophthalmol Otolaryngol 1974, 78:87-113.
88. Burton TC The influence of refractive error and lattice degeneration on the incidence of retinal detachment. Trans Am Ophthalmol Soc 1990, 87:143-157.
89. Parelhoff ES, Wood WJ, Green WR, et al. Radial perivascular lattice degeneration of the retina. Ann Ophthalmol 1980, 12:25-32.
90. Schepens CL Diagnostic and prognostic factors as found in preoperative examination. Trans Am Acad Ophthalmol Otolaryngol 1952, 56:398-418.
91. Schepens CL Subclinical retinal detachments. Arch Ophthalmol 1952, 47:593-606.
92. Foos RY, Simons KB, Wheeler NC Comparison of lesions predisposing to rhegmatogenous retinal detachment by race and subjects. Am J Ophthalmol 1983, 96:644-649.
93. Byer NE Clinical study of lattice degeneration of the retina. Trans Am Acad Ophthalmol Otolaryngol 1965, 69:1064-1077.
94. Robinson MR, Streeten BW The surface morphology of retinal breaks and lattice retinal degeneration: a scanning electron microscopic study. Ophthalmology 1986, 93:237-246.
95. Tillery WV, Lucier AC Round atrophic holes in lattice degeneration: an important cause of phakic retinal detachment. Trans Am Acad Ophthalmol Otolaryngol 1976, 81:509-518.
96. Morse PH, Scheie HG Prophylactic cryoretinopexy of retinal breaks. Arch Ophthalmol 1974, 92:204-207.
97. Byer NE Changes in prognosis of lattice degeneration of the retina. Trans Am Acad Ophthalmol Otolaryngol 1974, 78:114-124.
98. Davis MD Natural history of retinal breaks without detachment. Arch Ophthalmol 1974, 92:183-194.
99. Dobbie G Discussion. New research on the aetiology and surgery of retinal detachment. Mod Probl Ophthalmol 1975, 15:113.
100. Tolentino FI, Schepens CL, Freeman HM Vitreoretinal disorders: diagnosis and management 1976, WB Saunders, Philadelphia.
101. Byer NE The peripheral retina in profile: a stereoscopic atlas 1982, Criterion Press, Torrence, Calif.
102. Eisner G White with pressure. Biomicroscopy of the peripheral fundus: an atlas and textbook 1973, Springer-Verlag, New York. G. Eisner (Ed.).
103. Nagpal KC, Huamonte F, Constantaras A, et al. Migratory white-without-pressure retinal lesions. Arch Ophthalmol 1976, 94:576-579.
104. Watzke RC The ophthalmoscopic sign, "white with pressure": a clinicopathologic correlation. Arch Ophthalmol 1961, 66:812-823.
105. Daicker B Sind die symptome "weiss mit druck" und weiss ohne druck durche die periphere netzshantsklerose bedingt?. Mod Probl Ophthalmol 1975, 15:82-90.
106. Gartner J Discussion. New research on the aetiology and surgery of retinal detachment. Mod Probl Ophthalmol 1975, 15:112.
107. Freeman HM Fellow eyes of giant retinal breaks. Trans Am Ophthalmol Soc 1978, 76:343-382.
108. Nagpal KC, Goldberg MF, Asdourian G, et al. Dark-without-pressure fundus lesions. Br J Ophthalmol 1975, 59:476-479.
109. Dunker S, Glinz J, Faulborn J Morphologic studies of the peripheral vitreoretinal interface in humans reveal structures implicated in the pathogenesis of retinal tears. Retina 1997, 17:124-130.
110. Schepens CL Clinical aspects of pathologic changes of the vitreous body. Am J Ophthalmol 1954, 38:8-21.
111. Balazs EA, Denlinger JL Aging changes in the vitreous. Aging and human visual function 1982, Alan R Liss, New York.
112. Larsson L, Osterlin S Posterior vitreous detachment: a combined clinical and physicochemical study. Graefes Arch Clin Exp Ophthalmol 1985, 223:92-95.
113. O'Malley P The pattern of vitreous syneresis: a study of 800 autopsy eyes. Advances in vitreous surgery 1976, Charles C Thomas, Springfield, Ill. A.R. Irvine, C. O'Malley (Eds.).
114. Eisner G Zur anatomie des glaskorpers. Graefes Arch Clin Exp Ophthalmol 1975, 193:33-56.
115. Sebag J, Balazs EA Morphology and ultrastructure of human vitreous fibers. Invest Ophthalmol Vis Sci 1989, 30:1867-1871.
116. Kishi S, Shimizu K Posterior precortical vitreous pocket. Arch Ophthalmol 1990, 108:979-982.
117. Sebag J Letter to the editor. Arch Ophthalmol 1991, 109:1059-1060.
118. Denlinger JL, Eisner G, Balazs EA Age-related changes in the vitreous and lens of rhesus monkeys (Macaca mulatta). Exp Eye Res 1980, 31:67-79.
119. Snowden JM The stabilization of in vivo assembled collagen fibrils by proteoglycans/glycosaminoglycans. Biochem Biophys Acta 1982, 703:21-25.
120. Aiello AP Vascular endothelial growth factor and the eye. Arch Ophthalmol 1996, 114:1252-1254.
121. Kamei A, Totani A Isolation and characterization of minor glycosaminoglycans in the rabbit vitreous body. Biochem Biophys Res Commun 1982, 109:881-887.
122. Foos RY, Wheeler NC Vitreoretinal juncture: synchysis senilis and posterior vitreous detachment. Ophthalmology 1982, 89:1502-1512.
123. Goldmann H Senile changes of the lens and the vitreous. Am J Ophthalmol 1964, 57:1-13.
124. Murphy AI, Irvine AR Spontaneous release of retinal traction due to subretinal strands. Retina 1983, 3:273-276.
125. Takahashi M, Jalkh A, Hoskins J, et al. Biomicroscopic evaluation and photography of liquefied vitreous in some vitreoretinal disorders. Arch Ophthalmol 1981, 99:1555-1559.
126. Miller B, Miller H, Ryan SJ Experimental vitreous syneresis. Arch Ophthalmol 1985, 103:1385-1388.
127. Gartner J Electron microscopic observations on the cilio-zonular border of the human eye with particular reference to the aging changes. Anat Entwicklungsgesch 1970, 131:263.
128. Sebag J Imaging vitreous. Eye 2002, 16:429-439.
129. Foos RY Ultrastructural features of posterior vitreous detachment. Graefes Arch Clin Exp Ophthalmol 1975, 196:103-111.
130. Favre M, Goldmann H Zur genese der hinteren glaskorperabhebung. Ophthalmologica 1956, 132:86-97.
131. Pischel DK Detachment of the vitreous as seen with slit-lamp examination. Trans Am Ophthalmol Soc 1952, 50:329-346.
132. Buzney SM, Weiter JJ, Furukawa H, et al. Examination of the vitreous: a comparison of biomicroscopy using the Goldmann and El Bayadi-Kajiura lenses. Ophthalmology 1985, 92:1745-1748.
133. Fisher YL, Slakter JS, Friedman RA, et al. Kinetic ultrasound evaluation of the posterior vitreoretinal interface. Ophthalmology 1991, 98:1135-1138.
134. Ortiz RG, Lopez PF, Lambert HM, et al. Examination of macular vitreoretinal interface disorders with monochromatic photography. Am J Ophthalmol 1992, 113:243-247.
135. Ansari RR, Dunker S, Suh K Quantitative molecular characterization of bovine vitreous and lens with non-invasive dynamic light scattering. Exp Eye Res 2001, 73:859-866.
136. Sebag J, Ansari RR. Dynamic light scattering detection of posterior vitreous detachment. Proceedings of the SPIE Optical Engineering Society Annual Meeting, San Jose, California, January 1998. Ophthal Technol 1998; VIII.
137. Sebag J, Dunker S, Suh KI, et al. Dynamic light scattering measurements in vitreous. Invest Ophthalmol Vis Sci 1997, 38:662.
138. Wadsworth JAL The vitreous: gross and microscopic observations seen in age and disease with special emphasis on the role of vitreous in detachment of the retina. Trans Am Ophthalmol Soc 1956, 54:709-728.
139. Foos RY Posterior vitreous detachment. Trans Am Acad Ophthalmol Otolaryngol 1972, 76:480-497.
140. Grizzard WS, Hilton GF Scleral buckling for retinal detachments complicated by periretinal proliferation. Arch Ophthalmol 1982, 100:419-422.
141. Tasman WS Posterior vitreous detachment and peripheral retinal breaks. Trans Am Acad Ophthalmol Otolaryngol 1968, 72:217-224.
142. Boldrey EE Risk of retinal tears in patients with vitreous floaters. Am J Ophthalmol 1983, 96:783-787.
143. Tabotabo MM, Karp LA, Benson WE Posterior vitreous detachment. Ann Ophthalmol 1980, 12:59-61.
144. Murakami K, Jalkh AE, Avila MP, et al. Vitreous floaters. Ophthalmology 1983, 90:1271-1276.
145. Novak MA, Welch RB Complications of acute symptomatic posterior vitreous detachment. Am J Ophthalmol 1984, 97:308-314.
146. Byer NE Natural history of posterior vitreous detachment with early management as the premier line of defense against retinal detachment. Ophthalmology 1994, 101:1503-1514.
147. Eisner G The posterior hyaloid membrane. Biomicroscopy of the peripheral fundus: an atlas and textbook 1973, Springer-Verlag, New York. G. Eisner (Ed.).
148. Chu T, Lopez PF, Cano MR, et al. Posterior vitreoschisis: an echographic finding in proliferative diabetic retinopathy. Ophthalmology 1996, 103:315-322.
149. Sebag J Diabetic vitreopathy. (Editorial). Ophthalmology 1996, 103:205-206.
150. Gass JDM Macular dysfunction caused by vitreous and vitreoretinal interface abnormalities. Vitreous traction maculopathies. Stereoscopic atlas of macular diseases 1987, Mosby, St Louis.
151. Smiddy WE, Green WR, Michels RG, et al. Ultrastructural studies of vitreomacular traction syndrome. Am J Ophthalmol 1989, 107:177-185.
152. Smiddy WE, Michels RG, Green WR Morphology, pathology, and surgery of idiopathic vitreoretinal macular disorders, a review. Retina 1990, 10:288-296.
153. Smiddy WE, Michels RG, de Bustros S, et al. Histopathology of tissue removed during vitrectomy for impending idiopathic macular holes. Am J Ophthalmol 1989, 108:360-364.
154. Wolter JR Circular fixed fold of the retina. Am J Ophthalmol 1965, 60:805-811.
155. Spencer LM, Foos RY Paravascular vitreoretinal attachments: role in retinal tears. Arch Ophthalmol 1970, 84:557-564.
156. Brockhurst RJ, Schepens CL Vitreous hemorrhages: surgical treatment. Arch Ophthalmol 1961, 66:327-335.
157. Clark G The use of the photocoagulator in conditions associated with retinal detachment. Trans Am Acad Ophthalmol Otolaryngol 1962, 66:59-66.
158. Robertson DM, Curtin VT, Norton EWD Avulsed retinal vessels with retinal breaks: a cause of recurrent vitreous hemorrhage. Arch Ophthalmol 1971, 85:669-672.
159. Robertson DM, Norton EWD Long-term follow-up of treated retinal breaks. Am J Ophthalmol 1973, 75:395-404.
160. Theodossiadis GP, Velissatopoulos P, Magouritsas N, et al. Behandlung und Nachuntersuchung von Netzhautrissen ohne Netz-hautablosung mit den Riss uberlagerndem abgehobenem Netzhautgefass. Klin Monatsbl Augenheilkd 1977, 170:411-415.
161. de Bustros S, Welch RB The avulsed retinal vessel syndrome and its variants. Ophthalmology 1984, 91:86-88.
162. Lincoff H, Kreissig I, Richard G Treating avulsed vessels with a temporary balloon buckle. Am J Ophthalmol 1986, 101:90-94.
163. Theodossiadis GP, Koutsandrea CN Types of avulsed retinal vessels associated with rhegmatogenous retinal detachment: treatment and results. Graefes Arch Clin Exp Ophthalmol 1987, 225:185-188.
164. Chatzoulis D, Theodossiadis GP, Apostolopoulos M, et al. Rezidivierende Glaskorperblutungen infolge cines in die Glaskorperhohle hereingezogenen Netzhautgefalles. Klin Monatsbl Augenheilkd 1983, 183:256-258.
165. Hersh PS, Green WR, Thomas JV Tractional venous loops in diabetic retinopathy. Am J Ophthalmol 1981, 92:661-671.
166. Theodossiadis GP, Koutsandrea CN Avulsed retinal vessels with and without retinal breaks: treatment and extended follow-up. Trans Ophthalmol Soc UK 1985, 104:887-892.
167. Vine AK Avulsed retinal veins without retinal breaks. Am J Ophthalmol 1984, 98:723-727.
168. Meyer E, Kurz GH Retinal pits: a study of pathologic findings in two cases. Arch Ophthalmol 1963, 70:640-646.
169. Friedman Z, Neumann E, Hyams S Vitreous and peripheral retina in aphakia: a study of 200 nonmyopic aphakic eyes. Br J Ophthalmol 1973, 57:52-57.
170. Machemer R The importance of fluid absorption, traction, intraocular currents, and chorioretinal scars in the therapy of rhegmatogenous retinal detachments. Am J Ophthalmol 1984, 98:681-693.
171. Benson WE, Tasman W Rhegmatogenous retinal detachments caused by paravascular vitreoretinal traction. Arch Ophthalmol 1984, 102:669-670.
172. Butner RW, McPherson AR Spontaneous vitreous hemorrhage. Ann Ophthalmol 1982, 14:268-270.
173. Morse PH, Aminlari A, Scheie HG Spontaneous vitreous hemorrhage. Arch Ophthalmol 1974, 92:297-298.
174. Winslow RL, Taylor BC Spontaneous vitreous hemorrhage: etiology and management. South Med J 1980, 73:1450-1452.
175. DiBernardo C, Blodi B, Byrne SF Echographic evaluation of retinal tears in patients with spontaneous vitreous hemorrhage. Arch Ophthalmol 1992, 110:511-514.
176. Sigelman J Vitreous base classification of retinal tears: clinical application. Surv Ophthalmol 1980, 25:59-74.
177. Halpern JI Routine screening of the retinal periphery. Am J Ophthalmol 1966, 62:99-102.
178. Byer NE Clinical study of retinal breaks. Trans Am Acad Ophthalmol Otolaryngol 1967, 71:461-473.
179. Rutnin U, Schepens CL Fundus appearance in normal eyes. IV. Retinal breaks and other findings. Am J Ophthalmol 1967, 64:1063-1078.
180. Smith RE, Ganley JP Ophthalmic survey of a community. I. Abnormalities of the ocular fundus. Am J Ophthalmol 1972, 74:1126-1130.
181. Foos RY Retinal holes. Am J Ophthalmol 1978, 86:354-358.
182. Adamis AP, Shima DT, Tolentino MJ, et al. Inhibition of VEGF prevents retinal ischemia associated iris neovascularization in a nonhuman primate. Arch Ophthalmol 1996, 114:66-71.
183. Boniuk M, Butler FC An autopsy study of lattice degeneration, retinal breaks, and retinal pits. New and controversial aspects of retinal detachment 1968, Hoeber, New York. A. McPherson (Ed.).
184. Barishak YR, Stein R Retinal breaks without retinal detachment in autopsy eyes. Acta Ophthalmologica 1972, 50:147-159.
185. Foos RY Tears of the peripheral retina: pathogenesis, incidence, and classification in autopsy eyes. Mod Probl Ophthalmol 1975, 15:68-81.
186. Foos RY, Simons KB, Wheeler NC Comparison of lesions predisposing to rhegmatogenous retinal detachment by race and subjects. Am J Ophthalmol 1983, 96:644-649.
187. Colyear BH, Pischel DK Clinical tears in the retina without detachment. Am J Ophthalmol 1956, 41:773-792.
188. Byer NE Prognosis of asymptomatic retinal breaks. Arch Ophthalmol 1974, 92:208-210.
189. Byer NE The natural history of asymptomatic retinal breaks. Ophthalmology 1982, 89:1033-1039.
190. Neumann E, Hyams S Conservative management of retinal breaks: a follow-up study of subsequent retinal detachment. Br J Ophthalmol 1972, 56:482-486.
191. Haimann MH, Burton TC, Brown CK Epidemiology of retinal detachment. Arch Ophthalmol 1982, 100:289-292.
192. Michaelson IC, Stein R, Barkai S A study in the prevention of retinal detachment. Ann Ophthalmol 1969, 1:49-55.
193. Michels RG Vitreous surgery for macular pucker. Am J Ophthalmol 1981, 92:628-639.
194. Neumann E, Hyams S, Brakai S Natural history of retinal holes with specific reference to the development of retinal detachment and time factor involved. Causes and prevention of blindness 1972, Academic Press, New York. I.C. Michaelson, E.R. Berman (Eds.).
195. Bohringer HR Statistiches zu Haufigkeit and Risiko der Netz-hautablosung. Ophthalmologica 1956, 131:331-334.
196. Benson WE Prophylactic therapy of retinal breaks. Surv Ophthalmol 1977, 22:41-47.
197. Combs JL, Welch RB Retinal breaks without detachment: natural history, management, and long-term follow-up. Trans Am Ophthalmol Soc 1982, 80:64-97.
198. Smiddy WE, Flynn HW, Nicholson DH, et al. Results and complications in treated retinal breaks. Am J Ophthalmol 1991, 112:623-631.
199. Gass JDM, Norton WD Cystoid macular edema and papilledema following cataract extraction: a fluorescein funduscopic and angiographic study. Arch Ophthalmol 1966, 76:646-661.
200. Fine BS, Brucker AJ Macular edema and cystoid macular edema. Am J Ophthalmol 1981, 92:466-481.
201. Yanoff M, Fine BS, Brucker AJ, et al. Pathology of human cystoid macular edema. Surv Ophthalmol 1984, 28(suppl):505-511.
202. Coscas G, Gaudric A Natural course of nonaphakic cystoid macular edema. Surv Ophthalmol 1984, 28(suppl):471-484.
203. Bradford JD, Wilkinson CP, Bradford RH Cystoid macular edema following extracapsular cataract extraction and posterior chamber intraocular lens implantation. Retina 1988, 8:161-164.
204. Wright PL, Wilkinson CP, Balyeat HD, et al. Angiographic cystoid macular edema after posterior chamber lens implantation. Arch Ophthalmol 1988, 106:740-744.
205. Irvine AR Cystoid maculopathy. Surv Ophthalmol 1976, 21:1-17.
206. Sears ML Aphakic cystoid macular edema: the pharmacology of ocular trauma. Surv Ophthalmol 1984, 28(suppl):525-534.
207. Gartner S Optic neuritis and macular edema following cataract extraction. Eye Ear Nose Throat Monthly 1964, 43:45-49.
208. Thomas JV, Gragoudas ES, Blair NP, et al. Correlation of epinephrine use and macular edema in aphakic glaucomatous eyes. Arch Ophthalmol 1978, 96:625-628.
209. Calkins JL, Hochheimer BF Retinal light exposure from operation microscopes. Arch Ophthalmol 1979, 97:2363-2367.
210. Tso MOM, Fine BS, Zimmerman LE Photic maculopathy produced by the indirect ophthalmoscope. I. Clinical and histopathologic study. Am J Ophthalmol 1972, 73:686-699.
211. Jampol LM Aphakic cystoid macular edema: a hypothesis. Arch Ophthalmol 1985, 103:1134-1135.
212. Jampol LM, Kraff MC, Sanders DR, et al. Near UV radiation from the operating microscope and pseudophakic cystoid macular edema. Arch Ophthalmol 1985, 103:28-30.
213. Jampol LM, Sanders DR, Kraff MC Prophylaxis and therapy of aphakic cystoid macular edema. Surv Ophthalmol 1984, 28(suppl):535-539.
214. Kraff MC, Sanders DR, Jampol LM, et al. Effect of an ultraviolet-filtering intraocular lens on cystoid macular edema. Ophthalmology 1985, 92:366-369.
215. Iliff WJ Aphakic cystoid macular edema and the operating microscope: is there a connection?. Trans Am Ophthalmol Soc 1985, 83:476-500.
216. Cuncha-Vaz JG, Travassos A Breakdown of the blood-retinal barriers and cystoid macular edema. Surv Ophthalmol 1984, 28(suppl):485-492.
217. Miyake K Vitreous fluorophotometry in aphakic or pseudophakic eyes with persistent cystoid macular edema. Jpn J Ophthalmol 1985, 29:146-152.
218. Tso MOM Animal modeling of cystoid macular edema. Surv Ophthalmol 1984, 28(suppl):512-519.
219. Martin NF, Green WR, Martin LW Retinal phlebitis in the Irvine-Gass syndrome. Am J Ophthalmol 1977, 83:377-386.
220. Miyake Y A simplified method of treating retinal detachment with macular hole. Am J Ophthalmol 1984, 97:244-245.
221. Sears ML, Neufeld AH, Jampol LM Prostaglandins. Invest Ophthalmol 1973, 12:161-164.
222. Waitzman MB Possible new concepts relating prostaglandins to various ocular functions. Surv Ophthalmol 1970, 14:301-326.
223. Kraff MC, Sanders DR, Jampol LM, et al. Prophylaxis of pseudophakic cystoid macular edema with topical indomethacin. Ophthalmology 1982, 89:885-890.
224. Miyake K Prevention of cystoid macular edema after lens extraction by topical indomethacin. 1. A preliminary report. Graefes Arch Clin Exp Ophthalmol 1977, 203:81-88.
225. Miyake K Prevention of cystoid macular edema after lens extraction by topical indomethacin. II. A control study in bilateral extractions. Jpn J Ophthalmol 1978, 22:80-94.
226. Miyake K Indomethacin in the treatment of postoperative cystoid macular edema. Surv Ophthalmol 1984, 28:554-568.
227. Miyake K, Sakamura S, Miura H Long-term follow-up study on prevention of aphakic cystoid macular oedema by topical indomethacin. Br J Ophthalmol 1980, 64:324-328.
228. Yannuzzi LA A perspective on the treatment of aphakic cystoid macular edema. Surv Ophthalmol 1984, 28(suppl):540-553.
229. Yannuzzi LA, Landau AN, Turtz AI Incidence of aphakic cystoid macular edema with the use of topical indomethacin. Ophthalmology 1981, 88:947-953.
230. Flach AJ, Dolan BJ, Irvin AR Effectiveness of ketorolac tromethamine 0.5% ophthalmic solution for chronic aphakic and pseudophakic cystoid macular edema. Am J Ophthalmol 1987, 103:479-486.
231. Flach AJ, Stegman RC, Graham J, et al. Prophylaxis of aphakic cystoid macular edema without corticosteroids: a paired-comparison, placebo-controlled, double-masked study. Ophthalmology 1990, 97:1253-1258.
232. Miyake K, Miyake Y, Maekubo K, et al. Incidence of cystoid macular edema after retinal detachment surgery and the use of topical indomethacin. Am J Ophthalmol 1983, 95:451-456.
233. Jampol LM Pharmacologic therapy of aphakic cystoid macular edema: a review. Ophthalmology 1982, 89:891-897.
234. Jampol LM Pharmacologic therapy of aphakic and pseudophakic cystoid macular edema, 1985 update. Ophthalmology 1985, 92:807-810.
235. Yannuzzi LA, Klein RM, Wallyn RH, et al. Ineffectiveness of indomethacin in the treatment of chronic cystoid macular edema. Am J Ophthalmol 1977, 84:517-519.
236. Flach AJ, Jampol LM, Weinberg D, et al. Improvement in visual acuity in chronic aphakic and pseudophakic cystoid macular edema after treatment with topical 0.5% ketorolac tromethamine. Am J Ophthalmol 1991, 112:514-519.
237. Peterson M, Yozhizumi MO, Hepler R, et al. Topical indomethacin in the treatment of chronic cystoid macular edema. Graefes Arch Clin Exp Ophthalmol 1992, 230:401-405.
238. Cox SN, Hay E, Bird AC Treatment of chronic macular edema with acetazolamide. Arch Ophthalmol 1988, 106:1190-1195.
239. Marmor MF Hypothesis concerning carbonic anhydrase treatment of cystoid macular edema: example with epiretinal membrane. Arch Ophthalmol 1990, 108:1524-1525.
240. Steinmetz RL, Fitzke FW, Bird AC Treatment of cystoid macular edema with acetazolamide in a patient with serpiginous choroidopathy. Retina 1991, 11:412-415.
241. Jaffe NS Vitreous traction at the posterior pole of the fundus due to alterations in the vitreous posterior. Trans Am Acad Ophthalmol Otolaryngol 1967, 71:642-652.
242. Jaffe NS Complications of acute posterior vitreous detachment. Arch Ophthalmol 1968, 79:568-571.
243. Schepens CL Fundus changes caused by alterations of the vitreous body. Am J Ophthalmol 1955, 39:631-633.
244. Tolentino FI, Schepens CL Edema of posterior pole after cataract extraction. Arch Ophthalmol 1965, 74:781-786.
245. Schepens CL, Avila MP, Jalkh AE, et al. Role of the vitreous in cystoid macular edema. Surv Ophthalmol 1984, 28(suppl):499-504.
246. Sebag J, Balazs EA Pathogenesis of cystoid macular edema: an anatomic consideration of vitreoretinal adhesions. Surv Ophthalmol 1984, 28(suppl):493-498.
247. Boniuk M Cystic macular edema secondary to vitreoretinal traction. Surv Ophthalmol 1968, 13:118-121.
248. Reese AB, Jones IS, Cooper WC Macular changes secondary to vitreous traction. Trans Am Ophthalmol Soc 1966, 64:123-134.
249. Reese AB, Jones IS, Cooper WC Vitreomacular traction syndrome confirmed histologically. Am J Ophthalmol 1970, 69:975-977.
250. Wolter JR Cystoid macular edema in vitreo-retinal traction. Ophthalmic Surg 1981, 12:900-904.
251. Michels RG, Green WR, Maumenee AE Cystoid macular edema following cataract extraction (the Irvine-Gass syndrome): a case studied clinically and histopathologically. Ophthalmol Surg 1971, 2:217-221.
252. Wolter JR The histopathology of cystoid macular edema. Graefes Arch Clin Exp Ophthalmol 1981, 216:85-101.
253. Brownstein S, Orton R, Jackson WB Cystoid macular edema with equatorial choroidal melanoma. Arch Ophthalmol 1978, 96:2105-2107.
254. Gass JDM, Anderson DR, Davis EB A clinical fluorescein angiographic and electron microscopic correlation of cystoid macular edema. Am J Ophthalmol 1985, 100:82-86.
255. Newsom WA, Hood CI, Horwitz JA, et al. Cystoid macular edema: histopathologic and angiographic correlations: a clinicopathologic case report. Trans Am Acad Ophthalmol Otolaryngol 1972, 76:1005-1009.
256. Tso MOM Pathology of cystoid macular edema. Ophthalmology 1982, 89:902-915.
257. Vinores SA, Küchle M, Maklow J, et al. Blood-ocular barrier breakdown in eyes with ocular melanoma: a potential role for vascular endothelial growth factor/vascular permeability factor. Am J Pathol 1995, 147:1289-1297.
258. Bellhorn RW Analysis of animal models of macular edema. Surv Ophthalmol 1984, 28(suppl):520-524.
259. Fung WE Surgical therapy for chronic aphakic cystoid macular edema. Ophthalmology 1982, 89:898-901.
260. Fung WE The national prospective, randomized vitrectomy study for chronic aphakic cystoid macular edema: progress report and comparison between the control and nonrandomized groups. Surv Ophthalmol 1984, 28(suppl):569-575.
261. Fung WE, Vitrectomy-ACME Study Group Vitrectomy for chronic aphakic cystoid macular edema: results of a national, collaborative, prospective, randomized investigation. Ophthalmology 1985, 92:1102-1111.
262. Iliff CE Treatment of the vitreous-tug syndrome. Am J Ophthalmol 1966, 62:856-859.
263. Irvine SR A newly defined vitreous syndrome following cataract surgery. Am J Ophthalmol 1953, 36:559-619.
264. Katzen LY, Fleischman J, Trokel S YAG laser treatment of cystoid macular edema. Am J Ophthalmol 1983, 95:589-592.
265. Patel A, de Bustros S, Michels RG Pars plana vitrectomy for aphakic cystoid macular edema. Retina 1985, 5:11-15.
266. Gass JDM Nicotinic acid and maculopathy. Am J Ophthalmol 1973, 76:500-510.
267. Gass JDM Lamellar macular hole: a complication of cystoid macular edema after cataract extraction: a clinicopathologic case report. Trans Am Ophthalmol Soc 1975, 73:231-250.
268. Aaberg TM Macular holes: a review. Surv Ophthalmol 1970, 15:139-162.
269. Aaberg TM, Blair CJ, Gass JDM Macular holes. Am J Ophthalmol 1970, 69:555-562.
270. Lewis H, Cowan GM, Straatsma BR Apparent disappearance of a macular hole associated with development of an epiretinal membrane. Am J Ophthalmol 1986, 102:172-175.
271. Markham RH, Chignell AH Retinal detachment due to macular holes. Br J Ophthalmol 1981, 65:423-424.
272. Frangieh GT, Green WR, Engel HM A histopathologic study of macular cysts and holes. Retina 1981, 1:311-336.
273. Funata M, Wendel RT, de la Cruz Z, et al. Clinicopathologic study of bilateral macular holes treated with pars plana vitrectomy and gas tamponade. Retina 1992, 12:289-298.
274. Madreperla SA, Geiger GL, Funata M, et al. Clinicopathologic correlation of a macular hole treated by cortical vitreous peeling and gas tamponade. Ophthalmology 1994, 101:682-686.
275. Fekrat S, Wendel RT, de la Cruz Z, et al. Clinicopathologic correlation of an epiretinal membrane associated with a recurrent macular hole. Retina 1995, 15:53-57.
276. Ezra EE, Munro PMG, Chateris DG, et al. Macular hole opercula: ultrastructural features and clinicopathologic correlation. Arch Ophthalmol 1997, 15:1381-1387.
277. Yoon H, Brooks HL, Capone A, et al. Ultrastructure features of tissue removed during idiopathic macular hole surgery. Am J Ophthalmol 1996, 122:67-76.
278. Sadda SR, Campochiaro PA, de Juan E, et al. Histopathological features of vitreous removed at macular hole surgery. Arch Ophthalmol 1999, 117:478-484.
279. Guyer DR, Green WR Idiopathic macular holes and precursor lesions. Symposium on vitreous and retinal disease. Proceedings of the 1992 New Orleans Academy of Ophthalmology 1993, Kugler, New York.
280. Gass JDM Clinicopathologic correlation of surgically removed macular hole opercula. (Letter). Am J Ophthalmol 1996, 121:453-454.
281. Gass JDM Lamellar macular hole: a complication of cystoid macular edema after cataract extraction. Arch Ophthalmol 1976, 94:793-800.
282. Guyer DR, Green WR, de Bustros S, Fine SL Histopathologic features of idiopathic macular holes and cysts. Ophthalmology 1990, 97:1045-1051.
283. Bronstein MA, Trempe CL, Freeman HM Fellow eyes of eyes with macular holes. Am J Ophthalmol 1981, 92:757-761.
284. Margherio RR, Schepens CL Macular breaks. I. Diagnosis, etiology and observations. Am J Ophthalmol 1972, 74:219-232.
285. Margherio RR, Schepens CL Macular breaks. II. Management. Am J Ophthalmol 1972, 74:233-240.
286. McDonnell PJ, Fine SL, Hillis AI Clinical features of idiopathic macular cysts and holes. Am J Ophthalmol 1982, 93:777-786.
287. Avila MP, Jalkh AE, Murakami K, et al. Biomicroscopic study of the vitreous in macular breaks. Ophthalmology 1983, 90:1277-1283.
288. Morgan CM, Schatz H Idiopathic macular holes. Am J Ophthalmol 1985, 99:437-444.
289. Morgan CM, Schatz H Involutional macular thinning: a premacular hole condition. Ophthalmology 1986, 93:153-161.
290. Gass JDM Idiopathic senile macular hole. Arch Ophthalmol 1988, 106:629-639.
291. Gass JDM, Joondepth BC Observations concerning patients with suspected impending macular holes. Am J Ophthalmol 1990, 109:638-646.
292. Johnson RN, Gass JDM Idiopathic macular holes: observations, stages of formation, and implications for surgical intervention. Ophthalmology 1988, 95:917-924.
293. Jost BF, Hutton WL, Fuller DG, et al. Vitrectomy in eyes at risk for macular hole formation. Ophthalmology 1990, 97:843-847.
294. Mein CE, Flynn HW Recognition and removal of the posterior cortical vitreous during vitreoretinal surgery for impending macular hole. Am J Ophthalmol 1991, 111:611-613.
295. Smiddy WE, Michels RG, Glaser BM, et al. Vitrectomy for macular traction caused by incomplete vitreous separation. Arch Ophthalmol 1988, 106:624-628.
296. Gonvers M, Machemer R A new approach to treating retinal detachment with macular hole. Am J Ophthalmol 1982, 94:468-472.
297. Kelly NE, Wendel RT Vitreous surgery for idiopathic macular holes: results of a pilot study. Arch Ophthalmol 1991, 109:654-659.
298. Alexandridis E, Kohl-Eisenhut H Treatment of retinal detachment with macular hole. Graefes Arch Clin Exp Ophthalmol 1986, 224:11-12.
299. Federman JL, Folberg R, Ridley M, et al. Subretinal cellular bands. Trans Am Ophthalmol Soc 1983, 81:172-181.
300. Feman SS, Hepler RS, Straatsma BR Rhegmatogenous retinal detachment due to macular hole: management with cryotherapy and a Y-shaped sling. Arch Ophthalmol 1974, 91:371-375.
301. Leaver PK, Cleary PE Macular hole and retinal detachment. Trans Ophthalmol Soc UK 1975, 95:145-147.
302. Folkman J Klagsbrun M. Angiogenic factors. Science 1987, 235:442-447.
303. Glaser BM, Michels RG, Kupperman BD, et al. Transforming growth factor-β2 for the treatment of full-thickness macular holes: a prospective, randomized study. Ophthalmology 1992, 99:1162-1173.
304. Osterlin S Macromolecular composition of the vitreous in the aphakic owl monkey eye. Exp Eye Res 1978, 26:77-84.
305. Osterlin S Changes in the macromolecular composition of the vitreous produced by removal of the lens. Proceedings of the Twenty-first International Congress, Mexico. Excerpt Med Internat Congr Ser 1970, 222:1620-1623.
306. Kawano SI, Honda Y, Negi A Effects of biological stimuli on the viscosity of the vitreous. Acta Ophthalmol 1982, 60:977-991.
307. Gregor Z, Ryan SJ Combined posterior contusion and penetrating injury in the pig eye. II. Histological features. Br J Ophthalmol 1982, 66:799-804.
308. Heller MD, Straatsma BR, Foos RY Detachment of the posterior vitreous in phakic and aphakic eyes. Mod Probl Ophthalmol 1972, 10:23-36.
309. McDonnell PJ, Patel A, Green WR Comparison of intracapsular and extracapsular cataract surgery: histopathologic study of eyes obtained postmortem. Ophthalmology 1985, 92:1208-1223.
310. Bradford RH, Wilkinson CP Vitreous opacification after cataract extraction. Am J Ophthalmol 1987, 103:276-280.
311. Hui YN, Sorgente N, Ryan SJ Liquefaction of rabbit vitreous by ferrous ions. Curr Eye Res 1988, 7:655-660.
312. McDonnell PJ, de la Cruz ZC, Green WR Vitreous incarceration complicating cataract surgery: a light and electron microscopic study. Ophthalmology 1986, 93:247-253.
313. Lerman SL, Thrasher MD, Moran M Vitreous changes after neodymium-YAG laser irradiation of the posterior capsule or mid vitreous. Am J Ophthalmol 1984, 97:470-475.
314. Krauss JM, Puliafito CA, Miglior S, et al. Vitreous changes after neodymium-YAG laser photodisruption. Arch Ophthalmol 1986, 104:592-597.
315. Norton EW, Machemer R New approach to the treatment of selected retinal detachments secondary to vitreous loss at cataract surgery. Am J Ophthalmol 1971, 72:705-707.
316. Hughes WF, Owens WC Extraction of senile cataract: a statistical comparison of various techniques and the importance of preoperative survey. Am J Ophthalmol 1945, 28:40-49.
317. Welch RB, Cooper JC Macular edema, papilledema, and optic atrophy after cataract extraction. Arch Ophthalmol 1958, 59:665-675.
318. Snip RC, Kenyon KR, Green WR Retrocorneal fibrous membrane in the vitreous touch syndrome. Am J Ophthalmol 1975, 79:233-244.
319. Kirsch RE, Steinman W Spontaneous rupture of the anterior hyaloid membrane following intracapsular cataract surgery. Am J Ophthalmol 1954, 37:657-664.
320. Luntz MH, Rosenblatt M Malignant glaucoma. Surv Ophthalmol 1987, 32:73-93.
321. Freeman HM, Tolentino FL Proliferative vitreoretinopathy. Atlas of vitreoretinal surgery 1990, Thieme, New York.
322. Hauer Y, Barkay S Vitreous detachment in aphakic eyes. Br J Ophthalmol 1964, 43:341-343.
323. Jaffe NS, Light DS Vitreous changes produced by cataract surgery: a study of 1058 aphakic eyes. Arch Ophthalmol 1966, 76:541-553.
324. Osterlin S Vitreous changes after cataract extraction. Vitreous surgery and advances in fundus diagnosis and treatment 1977, Appleton-Century-Crofts, New York. H.M. Freeman, T. Hirose, C.L. Schepens (Eds.).
325. Osterlin S Changes in the vitreous with age. Trans Ophthalmol Soc UK 1975, 95:372-377.
326. Kirmani M, Ryan SJ In vitro measurement of contractile force of transvitreal membranes formed after penetrating ocular injury. Arch Ophthalmol 1985, 103:107-110.
327. Cox MS, Schepens CL, Freeman HM Retinal detachment due to ocular contusion. Arch Ophthalmol 1966, 76:678-685.
328. Cox MS Retinal breaks caused by blunt nonperforating trauma at the point of impact. Trans Am Ophthalmol Soc 1980, 78:414-466.
329. Greenwald MJ, Weiss A, Oesterle CS, et al. Traumatic retinoschisis in battered babies. Ophthalmology 1986, 93:618-625.
330. Han DP, Wilkinson WS Late ophthalmic manifestations of the shaken baby syndrome. J Pediatric Ophthalmol 1990, 27:299-303.
331. Massicotte SJ, Folberg R, Torczynski E, et al. Vitreoretinal traction and perimacular retinal folds in the eyes of deliberately traumatized children. Ophthalmology 1991, 98:1124-1127.
332. Eagling EM Perforating injuries involving the posterior segment. Trans Ophthalmol Soc UK 1975, 95:335-339.
333. Pockrand P, Naumann G, Probst P Ergebuisse der Behandlung perforieren der Augenverletzungen. Eine klinisch statische Studie. Klin Monatsbl Augenheilkd 1974, 165:419-426.
334. de Juan E, Sternberg P, Michels RG Penetrating ocular injuries: types of injuries and visual results. Ophthalmology 1983, 90:1318-1322.
335. Machemer R, Parel JM, Buettner H A new concept for vitreous surgery. I. Instrumentation. Am J Ophthalmol 1972, 73:1-7.
336. Brinton GS, Aaberg TM Changing aspects of management of ocular trauma. (Editorial). Am J Ophthalmol 1982, 94:258-260.
337. Faulborn J, Topping TM Proliferations in the vitreous cavity after perforating injuries: a histopathological study. Graefes Arch Clin Exp Ophthalmol 1978, 205:157-166.
338. Winthrop SR, Cleary PE, Minckler DS, et al. Penetrating eye injuries: a histopathological review. Br J Ophthalmol 1980, 64:809-817.
339. Hutton WL, Fuller DG Factors influencing final visual results in severely injured eyes. Am J Ophthalmol 1984, 97:715-722.
340. Cleary PE, Ryan SJ Experimental posterior penetrating eye injury in the rabbit. I. Method of production and natural history. Br J Ophthalmol 1979, 63:306-311.
341. Cleary PE, Ryan SJ Experimental posterior penetrating eye injury in the rabbit. II. Histology of wound, vitreous, and retina. Br J Ophthalmol 1979, 63:312-321.
342. Cleary PE, Ryan SJ Histology of wound, vitreous and retina in experimental posterior penetrating eye injury in the rhesus monkey. Am J Ophthalmol 1979, 88:221-231.
343. Cleary PE, Ryan SJ Method of production and natural history of experimental posterior penetrating eye injury in the rhesus monkey. Am J Ophthalmol 1979, 88:212-220.
344. Topping TM, Abrams GW, Machemer R Experimental double-perforating injury of the posterior segment in rabbit eyes: the natural history of intraocular proliferation. Arch Ophthalmol 1979, 97:735-742.
345. Abrams GW, Topping TM, Machemer R Vitrectomy for injury: the effect on intraocular proliferation following perforation of the posterior segment of the rabbit eye. Arch Ophthalmol 1979, 97:743-748.
346. Pilkerton AR, Rao NA, Marak GE, Woodward SC Experimental vitreous fibroplasia following perforating ocular injuries. Arch Ophthalmol 1979, 97:1707-1709.
347. Ussmann JH, Lazarides E, Ryan SJ Traction retinal detachment: a cell-mediated event. Arch Ophthalmol 1981, 99:869-872.
348. Gregor Z, Ryan SJ Combined posterior contusion and penetrating injury in the pig eye. I. A natural history study. Br J Ophthalmol 1982, 66:793-798.
349. Gregor Z, Ryan SJ Combined posterior contusion and penetrating injury in the pig eye. III. A controlled treatment trial of vitrectomy. Br J Ophthalmol 1983, 67:282-285.
350. Cleary PE, Ryan SJ Vitrectomy in penetrating eye injury: results of a controlled trial of vitrectomy in an experimental posterior penetrating eye injury in the rhesus monkey. Arch Ophthalmol 1981, 99:287-292.
351. Gregor Z, Ryan SJ Complete and core vitrectomies in the treatment of epiretinal posterior penetrating eye injury in the rhesus monkey. I. Clinical features. Arch Ophthalmol 1983, 101:441-445.
352. Gregor Z, Ryan SJ Complete and core vitrectomies in the treatment of epiretinal posterior penetrating eye injury in the rhesus monkey. II. Histologic features. Arch Ophthalmol 1983, 101:446-450.
353. Hsu HT, Ryan SJ Natural history of penetrating ocular injury with retinal laceration in the monkey. Graefes Arch Clin Exp Ophthalmol 1986, 224:1-6.
354. Campochiaro PA, Gaskin HC, Vinores SA Retinal cryopexy stimulates traction retinal detachment formation in the presence of an ocular wound. Arch Ophthalmol 1987, 105:1567-1570.
355. de Juan E, Sternberg P, Michels RG Timing of vitrectomy after penetrating ocular injuries. Ophthalmology 1984, 91:1072-1074.
356. Spalding SC, Sternberg P Controversies in the management of posterior segment ocular trauma. Retina 1990, 10:76-82.
357. Kuhn F, Morris R, Witherspoon D, et al. A standardized classification of ocular trauma. Ophthalmology 1996, 103:240-243.
358. Pieramici DJ, Sternberg P, Aaberg T, et al. Perspective: a system for classifying mechanical injuries of the eye (globe). Am J Ophthalmol 1997, 123:820-831.
359. Roth AM, Foos RY Surface wrinkling retinopathy in eyes enucleated at autopsy. Trans Am Acad Ophthalmol Otolaryngol 1971, 75:1047-1058.
360. Smiddy WE, Maguire AM, Green WR, et al. Idiopathic epiretinal membranes: ultrastructural characteristics and clinicopathologic correlation. Ophthalmology 1989, 96:811-821.
361. Schwartz D, de la Cruz ZC, Green WR, et al. Proliferative vitreoretinopathy ultrastructural study of 20 retroretinal membranes removed by vitreous surgery. Retina 1988, 8:275-281.
362. Wilkes SR, Mansour AM, Green WR Proliferative vitreoretinopathy: histopathology of retroretinal membranes. Retina 1987, 7:94-101.
363. Foos RY Nonvascular proliferative extraretinal retinopathies. Am J Ophthalmol 1978, 86:723-725.
364. Foos RY The spectrum of nonvascular proliferative extraretinopathies. Ocular pathology update 1980, Masson, New York. D.H. Nicholson (Ed.).
365. Foos RY Vitreoretinal juncture: simple epiretinal membranes. Graefes Arch Clin Exp Ophthalmol 1974, 189:231-250.
366. Scudder MJ, Eifrig DE Spontaneous surface wrinkling retinopathy. Ann Ophthalmol 1975, 7:333-341.
367. Maumenee AE Further advances in the study of the macula. Arch Ophthalmol 1967, 78:151-165.
368. Tanenbaum HL, Schepens CL, Elzeneiny I, et al. Macular pucker following retinal detachment surgery. Arch Ophthalmol 1970, 83:286-293.
369. Lobes LA, Burton TC The incidence of macular pucker after retinal detachment surgery. Am J Ophthalmol 1978, 85:72-77.
370. Michels RG, Gilbert HD Vitrectomy techniques in treatment of macular pucker following retinal reattachment surgery. Mod Probl Ophthalmol 1979, 20:196-201.
371. Michels RG Vitrectomy for macular pucker. Ophthalmology 1984, 91:1384-1388.
372. Green WR, Kenyon KR, Michels RG, et al. Ultrastructure of epiretinal membranes causing macular pucker after retinal reattachment surgery. Trans Ophthalmol Soc UK 1979, 99:63-77.
373. Wilkinson CP Recurrent macular pucker. Am J Ophthalmol 1979, 88:1029-1031.
374. Foos RY Surface wrinkling retinopathy. Vitreous surgery and advances in fundus diagnosis and treatment 1977, Appleton-Century-Crofts, New York. H.M. Freeman, T. Hirose, C.L. Schepens (Eds.).
375. Wise GN Preretinal macular fibrosis: an analysis of 90 cases. Trans Ophthalmol Soc UK 1972, 92:131-140.
376. Wise GN Clinical features of idiopathic preretinal macular fibrosis. Am J Ophthalmol 1975, 79:349-357.
377. Wise GN Relationship of idiopathic preretinal macular fibrosis to posterior vitreous detachment. Am J Ophthalmol 1975, 79:358-362.
378. Bellhorn MB, Friedman AH, Wise GN, et al. Ultrastructure and clinicopathologic correlation of idiopathic preretinal macular fibrosis. Am J Ophthalmol 1975, 79:366-373.
379. Messner KH Spontaneous separation of preretinal macular fibrosis. Am J Ophthalmol 1977, 83:9-11.
380. Wise GN Congenital preretinal macular fibrosis. Am J Ophthalmol 1975, 79:363-365.
381. Robertson DM, Buettner H Pigmented preretinal membranes. Am J Ophthalmol 1977, 83:824-829.
382. Cherfan GM, Smiddy WE, Michels RG, et al. Clinicopathologic correlation of pigmented epiretinal membranes. Am J Ophthalmol 1988, 106:536-545.
383. Clarkson JG, Green WR, Massof D A histopathological review of 168 cases of preretinal membrane. Am J Ophthalmol 1977, 84:1-17.
384. Machemer R Removal of preretinal membranes. Trans Am Acad Ophthalmol Otolaryngol 1976, 81:420-425.
385. Laqua H Pigmented macular pucker. Am J Ophthalmol 1978, 86:56-58.
386. Kampik A, Green WR, Michels RG, et al. Epiretinale membranen nach Photokoagulation (Postcoagulative Maculopathie). Ber Dtsch Ophthalmol Ges 1981, 78:593-598.
387. Michels RG A clinical and histopathologic study of epiretinal membranes affecting the macula and removed by vitreous surgery. Trans Am Ophthalmol Soc 1982, 80:580-656.
388. Rice TA, de Bustros S, Michels RG, et al. Prognostic factors in vitrectomy for epiretinal membranes of the macula. Ophthalmology 1986, 93:602-610.
389. Rodrigues MM, Newsome DA, Machemer R Further characterization of epiretinal membranes in human massive periretinal proliferation. Curr Eye Res 1981, 1:311-315.
390. Margherio RR, Cox MS, Trese MT, et al. Removal of epimacular membranes. Ophthalmology 1985, 92:1075-1083.
391. Hansen RI, Friedman AH, Gartner S, et al. The association of retinitis pigmentosa with preretinal macular gliosis. Br J Ophthalmol 1977, 61:597-600.
392. Sidd RJ, Fine SL, Owens SL, et al. Idiopathic preretinal gliosis. Am J Ophthalmol 1982, 94:44-48.
393. Schepens CL Retinal detachment and aphakia. Arch Ophthalmol 1951, 45:1-17.
394. Havener WH Massive vitreous retraction. Ophthalmol Surg 1973, 4:22-67.
395. Tolentino FI, Schepens CL, Freeman HM Massive preretinal retraction: a biomicroscopic study. Arch Ophthalmol 1967, 78:16-22.
396. Byer NE Spontaneous disappearance of early postoperative preretinal retraction. Arch Ophthalmol 1973, 90:133-135.
397. Trese MT, Chandler DB, Machemer R Subretinal strands: ultrastructural features. Graefes Arch Clin Exp Ophthalmol 1985, 223:35-40.
398. Matsumara M, Yamakawa R, Yoshimura N, et al. Subretinal strands: tissue culture and histological study. Graefes Arch Clin Exp Ophthalmol 1987, 225:341-345.
399. Wallyn RH, Hilton GF Subretinal fibrosis in retinal detachment. Arch Ophthalmol 1979, 97:2128-2129.
400. Kao SF, Morgan CM, Bergstrom TJ Subretinal fibrosis following cyclocryotherapy. Arch Ophthalmol 1987, 105:1175-1176.
401. Sternberg P, Machemer R Subretinal proliferation. Am J Ophthalmol 1984, 98:456-462.
402. Daicker B Constricting retroretinal membranes associated with traumatic retinal detachments. Graefes Arch Clin Exp Ophthalmol 1985, 222:147-153.
403. Thomas EL, Michels RG, Rice TA, et al. Idiopathic progressive unilateral vitreous fibrosis and secondary traction retinal detachment. Retina 1982, 21:134-144.
404. Lindsey PS, Michels RG, Luckenbach M, et al. Ultrastructure of epiretinal membrane causing retinal starfold. Ophthalmology 1983, 90:578-583.
405. Machemer R, Laqua H Pigment epithelium proliferation in retinal detachment (massive periretinal proliferation). Am J Ophthalmol 1975, 80:1-23.
406. Machemer R Pathogenesis and classification of massive periretinal proliferation. Br J Ophthalmol 1978, 62:737-747.
407. The Retina Society Terminology Committee The classification of retinal detachment with proliferative vitreoretinopathy. Ophthalmology 1983, 90:121-125.
408. Machemer R, Aaberg TM, Freeman HM, et al. An updated classification of retinal detachment with proliferative vitreoretinopathy. Am J Ophthalmol 1991, 112:159-165.
409. Charles S Vitreous microsurgery 1981, Williams & Wilkins, Baltimore.
410. Schepens CL Letter to the editor. Ophthalmology 1987, 94:201.
411. Pederson JE, Kenyon KR, Green WR, et al. Pathology of pars planitis. Am J Ophthalmol 1978, 86:762-774.
412. Kampik A, Kenyon KR, Michels RG, et al. Epiretinal and vitreous membranes: a comparative study of 56 cases. Arch Ophthalmol 1981, 99:1445-1454.
413. Vinores SA, Campochiaro PA, Conway BP Ultrastructural and electron-immunocytochemical characterization of cells in epiretinal membranes. Invest Ophthalmol Vis Sci 1990, 31:14-28.
414. Vinores SA, Campochiaro PA, McGehee R, et al. Ultrastructural and immunocytochemical changes in retinal pigment epithelium, retinal glia, and fibroblasts in vitreous culture. Invest Ophthalmol Vis Sci 1990, 31:2529-2545.
415. Newsome DA, Rodrigues MM, Machemer R Human massive periretinal proliferation: in vitro characteristics of cellular components. Arch Ophthalmol 1981, 99:873-880.
416. Wolter JR Uber besondere astroglia an der Innenflache der Retina. Klin Monatsbl Augenheilkd 1965, 129:224-230.
417. Rapoza PA, Michels RG, Semeraro RJ, et al. Vitrectomy for excision of intraocular larva (hypoderma species). Retina 1986, 6:99-104.
418. Green WR Diagnostic cytopathology of ocular fluid specimens. Ophthalmology 1984, 91:726-749.
419. Kenyon KR, Michels RG Ultrastructure of epiretinal membrane removed by pars plana vitreoretinal surgery. Am J Ophthalmol 1977, 83:815-823.
420. Maguire AM, Smiddy W, Green WR et al. Idiopathic epiretinal membranes: ultrastructural characteristics and clinicopathologic correlation. ARVO abstract, 1988.
421. Machemer R, Van Horn D, Aaberg TM Pigment epithelial proliferation in human retinal detachment with massive periretinal proliferation. Am J Ophthalmol 1978, 85:181-191.
422. Wallow IHL, Stevens TS, Greaser ML, et al. Actin filaments in contracting preretinal membranes. Arch Ophthalmol 1984, 102:1370-1375.
423. Stern WH, Fisher SK, Anderson DH, et al. Epiretinal membrane formation after vitrectomy. Am J Ophthalmol 1982, 93:757-772.
424. Weinsieder A, Radtke ND, Currier GJ, et al. Bovine RPE heterotransplants simulate proliferative vitreoretinopathy (PVR) in rabbits. Metab Pediatr Syst Ophthalmol 1987, 10:2-8.
425. Algvere P, Kock E Experimental epiretinal membranes induced by intravitreal carbon particles. Am J Ophthalmol 1983, 96:345-353.
426. Vidaurri-Leal J, Hohman R, Glaser BM Effect of vitreous on morphologic characteristics of retinal pigment epithelial cells: a new approach to the study of proliferative vitreoretinopathy. Arch Ophthalmol 1984, 102:1220-1223.
427. Hsu T, Dorey CK, Sorgente N, et al. Surgical removal of vitreous: its effect on intraocular fibroblast proliferation in the rabbit. Arch Ophthalmol 1984, 102:605-607.
428. Stahl JH, Miller DB, Conway BP, et al. Dexa-methasone and indomethacin attenuate cryopexy-induced breakdown of the blood ocular barrier. Graefes Arch Clin Exp Ophthalmol 1987, 225:418-420.
429. Campochiaro PA, Glaser BM Platelet-derived growth factor is chemotactic for human retinal pigment epithelial cells. Arch Ophthalmol 1985, 103:576-579.
430. Campochiaro PA, Glaser BM Mechanisms involved in retinal pigment epithelial cell chemotaxis. Arch Ophthalmol 1986, 104:277-280.
431. Yeo JH, Sadeghi J, Campochiaro PA, et al. Intravitreous fibronectin and platelet-derived growth factor: new model for traction retinal detachment. Arch Ophthalmol 1986, 104:417-421.
432. Harvey AK, Roberge F, Hjelmeland LM Chemotaxis of rat retinal glia to growth factors found in repairing wounds. Invest Ophthalmol Vis Sci 1987, 28:1092-1099.
433. Schneeberger SA, Hjelmeland LM, Tucker RP, et al. Vascular endothelial growth factor and fibroblastic growth factor 5 are co-localized in vascular and avascular epiretinal membranes. Am J Ophthalmol 1997, 124:447-454.
434. Ryan SJ The pathophysiology of proliferative vitreoretinopathy and its management. Am J Ophthalmol 1985, 100:188-193.
435. Machemer R Proliferative vitreoretinopathy (PVR): a personal account of its pathogenesis and treatment. Proctor Lecture. Invest Ophthalmol Vis Sci 1988, 29:1771-1783.
436. Grey RHB, Leaver PK Silicone oil in the treatment of massive preretinal retraction. I. Results in 105 eyes. Br J Ophthalmol 1979, 63:355-360.
437. Leaver PK, Grey RHB, Garner A Silicone oil injection in the treatment of massive preretinal retraction. II. Late complications in 93 eyes. Br J Ophthalmol 1979, 63:361-367.
438. Scott JD Treatment of massive vitreous retraction. Trans Ophthalmol Soc UK 1975, 95:429-432.
439. Sell CH, McCuen BW, Landers MB, et al. Long-term results of successful vitrectomy with silicone oil for advanced proliferative vitreoretinopathy. Am J Ophthalmol 1987, 103:24-28.
440. Bonnet M, Santamaria E, Mouche J Intraoperative use of pure perfluoropropane gas in the management of proliferative vitreoretinopathy. Graefes Arch Clin Exp Ophthalmol 1987, 225:299-302.
441. Chang S, Ozmert E, Zimmerman NJ Intraoperative perfluorocarbon liquids in the management of proliferative vitreoretinopathy. Am J Ophthalmol 1988, 106:668-674.
442. Lopez R, Chang S Long-term results of vitrectomy and perfluorocarbon gas for the treatment of severe proliferative vitreoretinopathy. Am J Ophthalmol 1992, 113:424-428.
443. Yoshida A, Ho PC, Schepens CL, et al. Severe proliferative vitreoretinopathy and retinal detachment. II. Surgical results with scleral buckling. Ophthalmology 1984, 91:1538-1543.
444. Machemer R Massive periretinal proliferation: a logical approach to therapy. Trans Am Ophthalmol Soc 1977, 75:556-586.
445. Machemer R, Laqua H A logical approach to the treatment of massive periretinal proliferation. Ophthalmology 1978, 85:584-593.
446. Sternberg P, Machemer R Results of conventional vitreous surgery for proliferative vitreoretinopathy. Am J Ophthalmol 1985, 100:141-146.
447. Treister G, Moisseiev J Combined pars plana vitrectomy and retinal surgery in massive periretinal proliferation. Ann Ophthalmol 1983, 15:670-675.
448. Michels RG Surgery of retinal detachment with proliferative vitreoretinopathy. Retina 1984, 4:63-83.
449. Chang S, Coleman DJ, Lincoff H, et al. Perfluoropropane gas in the management of proliferative vitreoretinopathy. Am J Ophthalmol 1984, 98:180-188.
450. Jalkh AE, Avila MP, Schepens CL, et al. Surgical treatments of proliferative vitreoretinopathy. Arch Ophthalmol 1984, 102:1135-1139.
451. de Bustros S, Michels RG Surgical treatment of retinal detachments complicated by proliferative vitreoretinopathy. Am J Ophthalmol 1984, 98:694-699.
452. The Silicone Study Group Proliferative vitreoretinopathy. Am J Ophthalmol 1985, 99:593-595.
453. Blumenkranz MS, Claflin AJ, Hajek AS Selection of therapeutic agents for intraocular proliferative disease: cell culture evaluation. Arch Ophthalmol 1984, 102:598-604.
454. Chandler DB, Hida T, Sheta S, et al. Improvement in efficacy of corticosteroid therapy in an animal model of proliferative vitreoretinopathy by pretreatment. Graefes Arch Clin Exp Ophthalmol 1987, 225:259-265.
455. Chandler DB, Rozakis G, de Juan E, et al. The effect of triamcinolone acetonide on a refined experimental model of proliferative vitreoretinopathy. Am J Ophthalmol 1985, 99:686-690.
456. Tornambe PE The arrest of massive periretinal proliferation: a case report. Retina 1981, 1:208-210.
457. Blumenkranz MS, Hernandez E, Ophir A, et al. 5-Fluorouracil: new applications in complicated retinal detachment for an established antimetabolite. Ophthalmology 1984, 91:122-130.
458. Blumenkranz MS, Ophir A, Claflin AJ, et al. Fluorouracil for the treatment of massive periretinal proliferation. Am J Ophthalmol 1982, 94:458-467.
459. Orr G, Tervaert DC, Lean JS Aqueous concentrations of fluorouracil after intravitreal injection: normal, vitrectomized, and silicone-filled eyes. Arch Ophthalmol 1986, 104:431-434.
460. Stern WH, Guerin CJ, Erickson PA, et al. Ocular toxicity of fluorouracil after vitrectomy. Am J Ophthalmol 1983, 96:43-51.
461. Kirmani M, Santana M, Sorgente N, et al. Antiproliferative drugs in the treatment of experimental proliferative vitreoretinopathy: control by daunomycin. Retina 1983, 3:269-272.
462. Wiedemann P, Sorgente N, Bekhor C, et al. Daunomycin in the treatment of experimental proliferative vitreoretinopathy: effective doses in vitro and in vivo. Invest Ophthalmol Vis Sci 1985, 26:719-725.
463. Weiss JF, Belkin M The effect of penicillamine on posttraumatic vitreous proliferation. Am J Ophthalmol 1981, 92:625-627.
464. Radtke ND, Weinsieder AD, Ballou RJ Pharmacological therapy for proliferative vitreoretinopathy. Graefes Arch Clin Exp Ophthalmol 1986, 224:230-233.
465. Wiedemann P, Sorgente N, Ryan SJ Proliferative vitreoretinopathy: the rabbit cell injection model for screening of antiproliferative drugs. J Pharmacol Methods 1984, 12:69-78.
466. de Juan E, Machemer R Spontaneous reattachment of the retina despite proliferative vitreoretinopathy. Am J Ophthalmol 1984, 97:428-433.
467. Sumers KD, Jampol LM, Goldberg MF, et al. Spontaneous separation of epiretinal membranes. Arch Ophthalmol 1980, 98:318-320.
468. Archer DB Treacher Collins Prize Essay, 1976. Neovascularization of the retina. Trans Ophthalmol Soc UK 1976, 96:471-493.
469. Henkind P Ocular neovascularization. Am J Ophthalmol 1978, 85:287-301.
470. Patz A Studies on retinal neovascularization. Invest Ophthalmol Vis Sci 1980, 19:1133-1138.
471. Patz A Clinical and experimental studies on retinal neovascularization. Am J Ophthalmol 1982, 94:715-743.
472. Wise GN Retinal neovascularization. Trans Am Ophthalmol Soc 1956, 54:729-826.
473. Folkman J, Klagsbrun M Angiogenic factors. Science 1987, 235:442-447.
474. Lobb RR, Fett JW Purification of two distinct growth factors from bovine neural tissue by heparin affinity chromatography. Biochemistry 1984, 23:6295-6299.
475. Gospodarowicz D, Bialecki H, Greenburg G Purification of the fibroblast growth factor activity from bovine brain. J Biol Chem 1978, 253:3736-3743.
476. Glaser BM, D'Amore PA, Michels RG, et al. Demonstration of vasoproliferative activity from mammalian retina. J Cell Biol 1980, 84:298-304.
477. Courty J, Loret C, Moenner M, et al. Bovine retina contains three growth factor activities with different affinity to heparin: eye-derived growth factor I, II, III. Biochemie 1985, 67:265-269.
478. Baird A, Esch F, Gospodarowicz D, et al. Retina- and eye-derived endothelial cell growth factors: partial molecular characterization and identity with acidic and basic fibroblast growth factors. Biochemistry 1985, 24:7855-7860.
479. De Larco JE, Todaro GJ Sarcoma growth factor (SGF): specific binding to epidermal growth factor (EGF) membrane receptors. J Cellular Physiol 1980, 102:267-277.
480. Schreiber AB, Winkler ME, Derynck R Transforming growth factor X: a more potent angiogenic mediator than epidermal growth factor. Science 1986, 232:1250-1253.
481. Heimark RL, Twardzik DR, Schwartz SM Inhibition of endothelial regeneration by type-beta transforming growth factor from platelets. Science 1986, 233:1078-1080.
482. Roberts AB, Sporn MB, Assoian PK, et al. Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci USA 1983, 83:4167-4171.
483. Wahl SM, Hunt DA, Wakefield LM, et al. Transforming growth factor type B induces monocyte chemotaxis and growth factor production. Proc Natl Acad Sci USA 1987, 84:5788-5792.
484. Leibovich SJ, Polverini PJ, Shepard HM, et al. Macrophage-induced angiogenesis is mediated by tumor necrosis factor X. Nature 1987, 329:630-632.
485. Folkman J, Klagsbrun M A family of angiogenic peptides. Nature 1987, 329:671-672.
486. Fett JW, Strydom DJ, Lobb RR, et al. Isolation and characterization of angiogenin, an angiogenic protein from human carcinoma cells. Biochemistry 1985, 24:5480-5486.
487. Ben Ezra D Neovasculogenic ability of prostaglandins, growth factors, and synthetic chemoattractants. Am J Ophthalmol 1978, 86:455-461.
488. Connor TB, Roberts AB, Sporn MB, et al. Correlation of fibrosis and transforming growth factor-beta type 2 levels in the eye. Am Soc Clin Invest 1989, 83:1661-1666.
489. Glaser BM, Campochiaro PA, Davis JL, et al. Retinal pigment epithelial cells release an inhibitor of neovascularization. Arch Ophthalmol 1985, 103:1870-1875.
490. Brem S, Preis I, Folkman J, et al. Inhibition of neovascularization by an extract derived from vitreous. Am J Ophthalmol 1977, 84:323-328.
491. Lutty GA, Mello RJ, Chandler C, et al. Regulation of cell growth by vitreous humor. J Cell Sci 1985, 76:53-65.
492. Adamis AP, Shima DT, Yeo KT, et al. Synthesis and secretion of vascular permeability factor/vascular endothelial growth factor by human retinal pigment epithelial cells. Biochem Biophys Res Commun 1993, 193:631-638.
493. Aiello LP Vascular endothelial growth factor: 20th-century mechanisms, 21st-century therapies. Invest Ophthalmol Vis Sci 1997, 38:1647-1652.
494. Aiello LP, Avery R, Arrigg PG, et al. VEGF in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 1994, 22:1480-1487.
495. Folkman J, Shing Y Angiogenesis. J Biol Chem 1992, 267:10931-10934.
496. Shweiki D, Itin A, Soffer D, et al. Vascular endothelial grown factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992, 359:843-845.
497. Adamis AP, Miller JW, Bernal MT, et al. Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol 1994, 118:445-450.
498. Tanaka Y, Katoh S, Hori S, et al. VEGF in diabetic retinopathy. Lancet 1997, 349:1520-1521.
499. Miller B, Miller H, Patterson R, Ryan SJ Retinal wound healing: cellular activity at the vitreoretinal interface. Arch Ophthalmol 1986, 104:281-285.
500. Tolentino MJ, Miller JW, Gragoudas ES, et al. Intravitreous injections of VEGF produce retinal ischemia and microangiopathy in an adult primate. Ophthalmology 1996, 103:1820-1828.
501. Minchenko A, Bauer T, Salceda S, et al. Hypoxic stimulation of VEGF expression in vitro and in vivo. Lab Invest 1994, 71:374-379.
502. Senger DR, Van de Water L, Brown LF, et al. Vascular permeability factor (VPF, VEGF) in tumor biology. Cancer Metastasis Rev 1993, 12:303-324.
503. Aiello LP, Northrup JM, Keyt BA, et al. Hypoxic regulation of vascular endothelial growth factor in retinal cells. Arch Ophthalmol 1995, 113:1538-1544.
504. Aguayo J, Glaser B, Mildvan A, et al. Study of vitreous liquefaction by NMR spectroscopy and imaging. Invest Ophthalmol Vis Sci 1985, 26:692-697.
505. Frank RN, Amin R, Kennedy A, et al. An aldose reductase inhibitor and aminoguanidine prevent VEGF expressions in rats with long term galactosemia. Arch Ophthalmol 1997, 115:1036-1047.
506. Casey R, Li WW Factors controlling ocular angiogenesis. Am J Ophthalmol 1997, 124:521-529.
507. Sebag J, Hageman GS Interfaces. (Editorial). Eur J Ophthalmol 2000, 10:1-3.